ArticleFrontiers in immunology2026
Neutrophil extracellular traps formation is associated with impaired clot retraction and fibrinolysis in asthma.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Asthma is associated with an elevated risk of venous thromboembolism and pulmonary embolism; its etiology is not completely understood. Objective: This study was designed to investigate whether the formation of neutrophil extracellular traps (NET) is associated with impaired clot retraction and fibrinolysis in the blood of patients with asthma. Methods: Groups of 50 patients with asthma and 40 healthy subjects were enrolled in this study. Clot retraction kinetics were assessed by optical method (using a digital camera); fibrinolysis was recorded by thromboelastometry; NET predictors in plasma or serum-citrullinated histone H3 concentration, myeloperoxidase activity, and cell-free DNA level-were measured by microplate immunoenzymatic, colorimetric, and fluorometric assays, respectively. Spirometry (FEV Results: We found the elevated NET predictors in the blood of patients with asthma, which notably correlate with significant inhibition of clot retraction and fibrinolysis compared to the control group. FENO was found to be the most closely correlated with impaired fibrinolysis and clot retraction among all clinical tests. Conclusion: It was concluded that the formation of NET in the blood of patients with asthma is associated with impairment of clot retraction and fibrinolysis, which may contribute to the formation of unstable thrombi. This may partially explain the elevated risk of venous thromboembolism and pulmonary embolism in asthma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.